Fuller & Thaler Asset Management, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$3.44 - $7.21 $928,559 - $1.95 Million	-269,930 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $3,861 - $5,076	900 Added 0.33%	269,930 $1.47 Million
Q2 2019 Aug 13, 2019	SELL	$6.6 - $7.8 $9,900 - $11,700	-1,500 Reduced 0.55%	269,030 $1.86 Million
Q1 2019 May 14, 2019	BUY	$5.76 - $8.95 $47,980 - $74,553	8,330 Added 3.18%	270,530 $1.88 Million
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $4,208 - $6,376	800 Added 0.31%	262,200 $1.53 Million
Q3 2018 Nov 13, 2018	BUY	$4.65 - $7.95 $1.22 Million - $2.08 Million	261,400 New	261,400 $1.97 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.23B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.